首页> 外文期刊>Journal of clinical gastroenterology >Further Defining the 2012 Multi-Society Task Force Guidelines for Surveillance of High-risk Adenomas Is a 3-Year Interval Needed for All Patients?
【24h】

Further Defining the 2012 Multi-Society Task Force Guidelines for Surveillance of High-risk Adenomas Is a 3-Year Interval Needed for All Patients?

机译:进一步定义2012年高风险腺瘤监测的多社会工作队指南是所有患者所需的3年间隔?

获取原文
获取原文并翻译 | 示例
       

摘要

Goals: We set out to determine whether variation from this 3-year follow-up interval was associated with the finding of subsequent high-risk adenoma (HRA). Background: HRAs include the following: (1) an adenoma measuring >= 10 mm, (2) >= 3 adenomas found during a single procedure, and (3) an adenoma with high-grade dysplasia or villous architecture. The current Multi-Society Task Force guideline for timing of surveillance colonoscopy after removal of a HRA is 3 years. Study: In 2016, we analyzed 495 patients who had a HRA removed during a 2008 colonoscopy. We compared the frequency of finding another HRA at follow-up intervals. We used the current guidelines as our referent group and performed logistical regression to identify whether any patient characteristics, procedural factors, or type of HRA predicted the development of HRAs on follow-up colonoscopy. Results: Individuals who followed-up at a median of 4.5 years did not have more HRA on follow-up compared with those who followed-up at 3 years (25.2% vs. 21.0%, P=0.062). These groups had similar baseline characteristics. Older individuals, male gender, having a history of polyps, and piecemeal resection of an HRA predicted future HRAs. The removal of >= 3 adenomas in 2008 as well as a combination of multiple, large, and advanced polyps showed a higher risk of future HRAs. Conclusions: The 2012 Multi-Society Task Force recommendation of 3-year follow-up after removal of HRAs may not apply to all patients. We showed that a combination of patient demographics, procedural factors, and pathology best determines the surveillance colonoscopy interval.
机译:目标:我们开始确定是否与此3年后续间隔的变异有关的结果与随后的高风险腺瘤(HRA)的发现有关。背景:HRA包括以下内容:(1)腺瘤测量> = 10mm,(2)> = 3个腺瘤在单一程序中发现,(3)具有高级别发育性或绒毛建筑的腺瘤。目前的多社会任务力指南用于去除HRA后监测结肠镜检查的时间是3年。研究:2016年,我们分析了495名患者在2008年结肠镜检查期间拆除了HRA。我们将在随访时间间隔内比较找到另一个HRA的频率。我们使用当前指南作为我们的参考组,并进行了物流回归,以确定是否有任何患者特征,程序因素或HRA的类型预测HRAS在随访结肠镜检查中的发育。结果:与3年后随访的人(25.2%与21.0%,P = 0.062)相比,随访4.5岁的中位于4.5岁的人没有更多的HRA。这些组具有相似的基线特征。老年人,男性性别,有息肉的历史,并逐渐切除了HRA预测未来的HRA。在2008年除去> = 3腺瘤以及多重,大型和高级息肉的组合表现出更高的未来HRA的风险。结论:2012年多社会工作队在删除HRA后的3年后续行动可能不适用于所有患者。我们表明,患者人口统计数据,程序因素和病理学的组合最佳地决定了监视结肠镜检查间隔。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号